Adoptive immunotherapy of acute leukemia: experimental and clinical results.

G Mathé, Jeanne Amiel, L Schwarzenberg, +2

PubMed

Cell TherapyImmunologyPathologyImmunotherapyAdoptive Immunotherapy +15

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

G Mathé, Jeanne Amiel, L Schwarzenberg, +6

BMJ

ImmunologyBlood CellPathologyImmunotherapyAplastic Anemia +15

Haematopoietic Chimera in Man After Allogenic (Homologous) Bone-marrow Transplantation

G Mathé, Jeanne Amiel, L Schwarzenberg, +2

BMJ

TransplantationBone-marrow TransplantationMarrow TransplantationStem Cell TransplantationHematology +2

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Françis Lévi, Manuel Benavides, C. Chevelle, +7

Journal of Clinical Oncology

New AnthracyclineAdvanced Ovarian CancerMedicinePharmacologyGynecology +11

Homologous Human Kidney Transplantation

R Küss, M Legrain, G Mathé, +2

Postgraduate Medical Journal

Solid Organ TransplantationRenal PathologyTransplantation MedicineTissue TransplantationSurgery +14

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

G Mathé, L Schwarzenberg, P Pouillart, +10

Cancer

PathologyPharmacotherapyMetronomic ChemotherapyTumor BiologyVp 16213 +14

DEGREE OF BRONCHIAL METAPLASIA IN HEAVY SMOKERS AND ITS REGRESSION AFTER TREATMENT WITH A RETINOID

J. Gouveia, Thierry Hercend, G Lemaigre, +11

The Lancet

Tobacco ControlBronchial NeoplasmMedicineSmoking Related Lung DiseaseLung Cancer +1

Experimental Screening for “Systemic Adjuvants of Immunity” Applicable in Cancer Immunotherapy

G Mathé, M Dezfulian, O Hallé-Pannenko, +1

Recent results in cancer research/Recent Results in Cancer Research

Cancer ImmunosurveillanceAllergyImmunologyTumor Immunity“ Systemic Adjuvants +7

Circadian and/or circahemidian rhythms in nine lymphocyte-related variables from peripheral blood of healthy subjects.

Françis Lévi, C Canon, Jean-Pierre Blum, +3

The Journal of Immunology

Healthy SubjectsLaboratory ImmunologyImmunologyBlood CellPeripheral Blood +15

Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.

G Mathé, J. L. Misset, F. de Vassal, +10

PubMed

Iv PushPharmacotherapyImmunotherapyAcute LeukemiaMyeloid Neoplasia +14